drugset / Trial / NCT05784597
A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The primary objectives of this trial are to evaluate the safety and dosimetry of \[68Ga\]Ga-OncoFAP for detection/imaging of solid tumors.
Timeline
- Start
- 2023-04-27
- Primary completion
- 2024-10-21
- Completion
- 2024-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [68Ga]Ga-OncoFAP | Diagnostic / imaging agent | 250 mbq | Intravenous |